United States · FDA National Drug Code directory
TYENNE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65219-594_363d125e-6d69-4bb2-ae09-5eeb5d9edbae
- Product NDC
- 65219-594
- Form
- INJECTION, SOLUTION, CONCENTRATE
- Composition / generic term
- Tocilizumab-aazg
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 20240415
- Source listing expiry
- 20271231
Source-listed ingredients
- TOCILIZUMAB — 400 mg/20mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (65219-594-20) / 20 mL in 1 VIAL, SINGLE-DOSE · 65219-594-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →